Nevertheless, despite this positive preclinical evidence, caution is advised against the use of TNF‐α antibodies for ICI myocarditis and HF,1 as clinical studies in HF patients have shown neutral or even negative outcomes.95 The gene discussed is TNF; the disease is myocarditis.